{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T20:21:38Z","timestamp":1773951698135,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,8,17]],"date-time":"2011-08-17T00:00:00Z","timestamp":1313539200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Parasitol Res"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s00436-011-2599-6","type":"journal-article","created":{"date-parts":[[2011,8,17]],"date-time":"2011-08-17T17:33:22Z","timestamp":1313602402000},"page":"1113-1117","source":"Crossref","is-referenced-by-count":38,"title":["The effect of verapamil on in vitro susceptibility of promastigote and amastigote stages of Leishmania tropica to meglumine antimoniate"],"prefix":"10.1007","volume":"110","author":[{"given":"Azar","family":"Shokri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iraj","family":"Sharifi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Khamesipour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nozar","family":"Nakhaee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majid","family":"Fasihi Harandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jafar","family":"Nosratabadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Hakimi Parizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Barati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,8,17]]},"reference":[{"key":"2599_CR1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0065-308X(05)61006-8","volume":"61","author":"J Alvar","year":"2006","unstructured":"Alvar J, Croft S, Olliaro P (2006) Chemotherapy in the treatment and control of leishmaniasis. Adv Parasitol 61:223\u2013274","journal-title":"Adv Parasitol"},{"key":"2599_CR2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1146\/annurev.pa.36.040196.001113","volume":"36","author":"WT Bellamy","year":"1996","unstructured":"Bellamy WT (1996) P-glycoprotein and multidrug resistance. Annu Rev Pharmacol Toxicol 36:161\u2013183","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"2599_CR3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1006\/expr.2000.4537","volume":"95","author":"MC Carrio","year":"2000","unstructured":"Carrio MC, Reiva C, Gallego M, Arboix M, Portus M (2000) Leishmania infantum: stage specific activity of pentavalent antimony related with the assay conditions. Exp Parasitol 95:209\u2013214","journal-title":"Exp Parasitol"},{"issue":"1","key":"2599_CR4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1128\/CMR.19.1.111-126.2006","volume":"19","author":"SL Croft","year":"2006","unstructured":"Croft SL, Sundar S, Fairlamb AH (2006) Drug resistance in leishmaniasis. Clin Microbiol Rev 19(1):11\u201326","journal-title":"Clin Microbiol Rev"},{"key":"2599_CR5","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","volume":"27","author":"P Desjeux","year":"2004","unstructured":"Desjeux P (2004) Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 27:305\u2013318","journal-title":"Comp Immunol Microbiol Infect Dis"},{"issue":"12","key":"2599_CR6","doi-asserted-by":"crossref","first-page":"71575","DOI":"10.1001\/archderm.142.12.1575","volume":"142","author":"A Firooz","year":"2006","unstructured":"Firooz A, Khamesipour A, Ghoorchi MH, Nassiri-Kashani M, Eskandari SE, Khatami A, Hooshmand B, Gorouhi F, Rashighi-Firoozabadi M, Dowlati Y (2006) Imiquimod in combination with meglumine antimoniate for cutaneous leishmaniasis. Arch Dermatol 142(12):71575\u201371579","journal-title":"Arch Dermatol"},{"issue":"5","key":"2599_CR7","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1371\/journal.pmed.0030162","volume":"3","author":"R Hadighi","year":"2006","unstructured":"Hadighi R, Mohebali M, Boucher P, Hajjaran H, Khamesipour A, Ouellette M (2006) Unresponsiveness to glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites. PLoS Med 3(5):659\u2013667","journal-title":"PLoS Med"},{"issue":"5","key":"2599_CR8","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00436-007-0638-0","volume":"101","author":"R Hadighi","year":"2007","unstructured":"Hadighi R, Boucher P, Khamesipour A, Meamar AR, Roy G, Ouellette M, Mohebali M (2007) Glucantime-resistant Leishmania tropica isolated from Iranian patients with cutaneous leishmaniasis are sensitive to alternative antileishmania drugs. Parasitol Res 101(5):1319\u20131322","journal-title":"Parasitol Res"},{"issue":"3","key":"2599_CR9","first-page":"389","volume":"123","author":"TK Jha","year":"2006","unstructured":"Jha TK (2006) Drug unresponsiveness and combination therapy for kala-azar. Indian J Med Res 123(3):389\u2013398","journal-title":"Indian J Med Res"},{"issue":"2","key":"2599_CR10","doi-asserted-by":"crossref","first-page":"335.e1","DOI":"10.1016\/j.jaad.2007.01.016","volume":"57","author":"A Khatami","year":"2007","unstructured":"Khatami A, Firooz A, Gorouhi F, Dowlati Y (2007) Treatment of acute Old World cutaneous leishmaniasis: a systematic review of the randomized controlled trials. J Am Acad Dermatol 57(2):335.e1\u201329","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"2599_CR11","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4269\/ajtmh.2009.80.172","volume":"80","author":"P Layegh","year":"2009","unstructured":"Layegh P, Pezeshkipoor F, Soruri AH, Navaifar P, Moghyman T (2009) Efficacy of cryotherapy versus intralesional meglumine antimoniate (glucantime) for treatment of cutaneous leishmaniasis in children. Am J Trop Med Hyg 80(2):172\u2013175","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"2599_CR12","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1086\/314896","volume":"180","author":"R Lira","year":"1999","unstructured":"Lira R, Sundar S, Makharia A, Kenney R, Gam A, Saraiva E, Sakhs D (1999) Evidence that the high incidence of treatment failure in Indian Kala azar is due the emergence of antimony resistant strains of Leishmania donovani. J Infect Dis 180(2):564\u2013567","journal-title":"J Infect Dis"},{"key":"2599_CR13","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1126\/science.3544220","volume":"235","author":"SK Martin","year":"1987","unstructured":"Martin SK, Oduola AM, Milhous WK (1987) Reversal of chloroquine resistance in Plasmodium falciparum by verapamil. Science 235:899\u2013901","journal-title":"Science"},{"key":"2599_CR14","doi-asserted-by":"crossref","unstructured":"Modabber F, Buffet PA, Torreele1 E, Milon G, Croft SL (2007) Consultative meeting to develop a strategy for treatment of cutaneous leishmaniasis. Institute Pasteur, Paris 13\u201315June, 2006. Kinetoplastid Biol Dis 24(6):3.","DOI":"10.1186\/1475-9292-6-3"},{"issue":"1","key":"2599_CR15","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00436-010-2073-x","volume":"108","author":"D Moreno","year":"2011","unstructured":"Moreno D, Plano D, Baquedano Y, Jim\u00e9nez-Ruiz A, Palop JA, Sanmartin C (2011) Antileishmanial activity of imidothiocarbamates and imidoselenocarbamates. Parasitol Res 108(1):233\u2013239","journal-title":"Parasitol Res"},{"issue":"2","key":"2599_CR16","first-page":"123","volume":"18","author":"R Pour","year":"2011","unstructured":"Pour R, Sharifi I, Kazemi B, Zarean M (2011) Identification of nonresponsive isolates to glucantime in patients with cutaneous leishmaniasis in Bam. J Kerman Univ Med Sci 18(2):123\u2013133","journal-title":"J Kerman Univ Med Sci"},{"issue":"8","key":"2599_CR17","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/PL00008548","volume":"86","author":"V Prasad","year":"2000","unstructured":"Prasad V, Kaur J, Dey CS (2000) Arsenite-resistant Leishmania donovani promastigotes express an enhanced membrane P-type adenosine triphosphatase activity that is sensitive to verapamil treatment. Parasitol Res 86(8):661\u2013664","journal-title":"Parasitol Res"},{"key":"2599_CR18","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.exppara.2006.02.015","volume":"114","author":"ML Ranjini Valiathan","year":"2006","unstructured":"Ranjini Valiathan ML, Dubey RC et al (2006) Leishmania donovani: Effect of verapamil on in vitro susceptibility of promastigote and amastigote stages of Indian clinical isolates to sodium stibogluconate. Exp Parasitol 114:103\u2013108","journal-title":"Exp Parasitol"},{"issue":"4","key":"2599_CR19","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00436-010-2230-2","volume":"108","author":"N Shakya","year":"2011","unstructured":"Shakya N, Sane SA, Gupta S (2011) Antileishmanial efficacy of fluconazole and miltefosine in combination with an immunomodulator\u2013picroliv. Parasitol Res 108(4):793\u2013800","journal-title":"Parasitol Res"},{"key":"2599_CR20","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1365-4632.2010.04419.x","volume":"49","author":"I Sharifi","year":"2010","unstructured":"Sharifi I, Fekri AR, Aflatoonian MR, Khamesipour A, Mahboudi F, Dowlati Y, Nadim A, Modabber F (2010) Leishmaniasis recidivans among school children in Bam, South-east Iran, 1994\u20132006. Int J Dermatol 49:557\u2013561","journal-title":"Int J Dermatol"},{"issue":"5","key":"2599_CR21","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s00436-010-2176-4","volume":"108","author":"M Tafaghodi","year":"2011","unstructured":"Tafaghodi M, Khamesipour A, Jaafari MR (2011) Immunization against leishmaniasis by PLGA nanospheres encapsulated with autoclaved Leishmania major (ALM) and CpG-ODN. Parasitol Res 108(5):1265\u20131273","journal-title":"Parasitol Res"}],"container-title":["Parasitology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-011-2599-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00436-011-2599-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-011-2599-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T04:24:32Z","timestamp":1560486272000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00436-011-2599-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,17]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["2599"],"URL":"https:\/\/doi.org\/10.1007\/s00436-011-2599-6","relation":{},"ISSN":["0932-0113","1432-1955"],"issn-type":[{"value":"0932-0113","type":"print"},{"value":"1432-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,17]]}}}